Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Accumulated Expenses (2020 - 2025)

iSpecimen has reported Accumulated Expenses over the past 6 years, most recently at $619242.0 for Q4 2025.

  • For Q4 2025, Accumulated Expenses fell 47.02% year-over-year to $619242.0; the TTM value through Dec 2025 reached $619242.0, down 47.02%, while the annual FY2025 figure was $619242.0, 47.02% down from the prior year.
  • Accumulated Expenses for Q4 2025 was $619242.0 at iSpecimen, down from $716878.0 in the prior quarter.
  • Over five years, Accumulated Expenses peaked at $1.7 million in Q1 2024 and troughed at $7510.0 in Q3 2021.
  • A 5-year average of $813949.2 and a median of $882274.0 in 2023 define the central range for Accumulated Expenses.
  • Biggest five-year swings in Accumulated Expenses: crashed 99.78% in 2021 and later skyrocketed 18649.09% in 2022.
  • Year by year, Accumulated Expenses stood at $8167.0 in 2021, then skyrocketed by 18649.09% to $1.5 million in 2022, then grew by 0.61% to $1.5 million in 2023, then fell by 24.13% to $1.2 million in 2024, then tumbled by 47.02% to $619242.0 in 2025.
  • Business Quant data shows Accumulated Expenses for ISPC at $619242.0 in Q4 2025, $716878.0 in Q3 2025, and $645567.0 in Q2 2025.